SCHEDULE: FMR LLC Discloses 8.5% Stake in Wave Life Sciences
Beneficial Ownership Report
FMR LLC and its affiliates, including Abigail P. Johnson, reported beneficial ownership of 8.5% of Wave Life Sciences Ltd.'s common stock as of December 31, 2025.
Summary
- FMR LLC and its affiliates, including Abigail P. Johnson, collectively reported beneficial ownership of 15,020,982.62 shares of Wave Life Sciences Ltd. common stock.
- This represents an 8.5% stake in the company's common stock.
- FMR LLC holds sole voting power over 15,016,629 shares and sole dispositive power over 15,020,982.62 shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Wave Life Sciences Ltd.
- Subsidiaries of FMR LLC, including FIAM LLC, Fidelity Management & Research Company LLC, Fidelity Management Trust Company, and Strategic Advisers LLC, are involved in the beneficial ownership, with Fidelity Management & Research Company LLC beneficially owning 5% or greater of the outstanding shares.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as a significant stake by a reputable institutional investor like FMR LLC suggests a degree of confidence in Wave Life Sciences Ltd., although the filing itself is purely informational regarding ownership.
Positives
- A significant institutional investor, FMR LLC (Fidelity), holds an 8.5% stake, indicating confidence or a long-term investment perspective in Wave Life Sciences Ltd.
Future Outlook
NA
Management Comments
- The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.
Industry Context
StockSavvy.ai notes that the disclosure of a significant stake by a major asset manager like FMR LLC (Fidelity) in Wave Life Sciences Ltd. can often be interpreted by the market as a vote of confidence in the company's long-term prospects or its strategic direction. This type of institutional investment can attract further investor attention, particularly in the life sciences sector where R&D success and market adoption are critical.
Comparison to Industry Standards
- StockSavvy.ai observes that an 8.5% beneficial ownership stake by a single institutional entity like FMR LLC is a substantial position, often placing the investor among the top shareholders. For example, similar significant stakes are held by major asset managers in other life sciences companies, such as BlackRock's 7.1% stake in Moderna (MRNA) or Vanguard's 8.9% stake in BioNTech (BNTX), reflecting a common strategy for large funds to build meaningful positions in promising companies within their investment mandates.
Related Party Transactions
- Abigail P. Johnson, a reporting person, is a Director, Chairman, and CEO of FMR LLC, the other reporting person.
- Members of the Johnson family, including Abigail P. Johnson, are the predominant owners of Series B voting common shares of FMR LLC, representing 49% of its voting power, and form a controlling group with respect to FMR LLC.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake may increase investor confidence and potentially attract more investment, positively impacting share price.
- Management: A large institutional investor may exert influence through engagement, though the filing states the stake is not for changing control.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-10 | Date of Schedule 13G filing by FMR LLC referencing the Power of Attorney (accession number: -23-000003). |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | Date of Schedule 13G filing by FMR LLC referencing Abigail P. Johnson's Power of Attorney (accession number: -23-000038). |
| 2025-12-31 | Reporting period end date for beneficial ownership. |
| 2026-02-04 | Date of filing of this Schedule 13G statement. |
Recommendation
holdThe filing indicates a substantial 8.5% beneficial ownership by FMR LLC, a major institutional investor, in Wave Life Sciences Ltd. While this is a positive indicator of institutional confidence, the Schedule 13G itself does not provide operational or financial performance data to warrant a 'buy' or 'sell' recommendation. The 'hold' recommendation reflects the stability implied by a significant institutional stake, suggesting that current investors may maintain their positions, and new investors should conduct further due diligence beyond this ownership disclosure.
Keywords
Wave Life Sciences Ltd, FMR LLC, Fidelity, Abigail P. Johnson, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investor, Life Sciences, Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.